1. Home
  2. |Insights
  3. |EEOC Delays Collection of 2019 EEO-1 Data Until 2021

EEOC Delays Collection of 2019 EEO-1 Data Until 2021

Client Alert | 1 min read | 05.08.20

On May 7, 2020, the U.S. Equal Employment Opportunity Commission (EEOC) announced that it will delay its collection of 2019 EEO-1 Component 1 data collection until 2021, in recognition of challenges currently facing employers given the Coronavirus Disease 2019 (COVID-19) pandemic. The EEOC anticipates that it will begin collecting 2019 and 2020 EEO-1 Component 1 data in March, 2021, and will notify filers of the precise date on which they may begin filing as soon as that information is available. Despite the temporary reprieve, employers should continue to collect and maintain the necessary race, ethnicity, gender, and EEO-1 category data required to complete the report. Last Fall, the EEOC stated that it would not seek Office of Management and Budget (OMB) approval to collect the “Component 2” compensation and hours data it was ultimately required to collect for 2017 and 2018, so employers will only need to submit Component 1 demographic data when filing resumes. 

Contacts

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...